Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 26 January 1996:
Vol. 271. no. 5248, pp. 446 - 447
DOI: 10.1126/science.271.5248.446
Prev | Table of Contents | Next

Research News

Jean Marx

Although neurobiologists have known for 3 years that mutations in the SOD1 gene cause some cases of familial amyotrophic lateral sclerosis (FALS), finding out exactly how those mutations cause the deadly neurodegeneration of the disease has proved tougher than expected. But two reports, one appearing on page 515 of this issue and the other in the February Annals of Neurology, now suggest that one way the mutations act is by increasing the ability of the enzyme encoded by SOD1 to carry out peroxidation, a potentially toxic reaction that may lead to membrane degeneration and neuronal cell death. If so, then it may be possible to design better ALS therapies aimed at blocking the peroxidation reaction.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)